Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: "eye"
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"CADTH Canadian Drug Expert Committee"
language:"English"
Showing
1
-
7
of
7
Search:
'"eye"'
,
query time: 0.01s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
CADTH Canadian Drug Expert Committee recommendation: Voretigene neparvovec (Luxturna -- Novartis Pharmaceuticals Canada Inc.) : indication : vision loss, inherited retinal dystroph...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... for subretinal injection and the Health Canada-approved dose is 1.5 x 1011 vector genomes (vg) for each
eye
...
”
Read Now
2
CADTH Canadian Drug Expert Committee recommendation: Latanoprostene bunod (Vyzulta -- Bausch Health, Canada Inc.) : indication : for the reduction of intraocular pressure (IOP) in...
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
... documented diagnosis of open-angle glaucoma or ocular hypertensionin one or both
eyes
. Pricing condition...
”
Read Now
3
CADTH Canadian Drug Expert Committee recommendation: Latanoprostene bunod (Vyzulta -- Bausch Health, Canada Inc.) : indication : for the reduction of intraocular pressure (IOP) in...
Published 2019
Canadian Agency for Drugs and Technologies in Health
“
... documented diagnosis of open-angle glaucoma or ocular hypertensionin one or both
eyes
. Pricing condition...
”
Read Now
4
Optimal use of minimally invasive glaucoma surgery: A health technology assessment : project protocol
Published 2018
CADTH
“
... known cause, include elevated intraocular pressure (IOP; i.e., pressure inside the
eyes
), increasing age...
”
Read Now
5
Optimal use of minimally invasive glaucoma surgery: A health technology assessment : project protocol
Published 2018
CADTH
“
... known cause, include elevated intraocular pressure (IOP; i.e., pressure inside the
eyes
), increasing age...
”
Read Now
6
Clinical review report: Upadacitinib (Rinvoq) (AbbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... as well, including the
eyes
, lungs, heart, or skin. It is estimated that about 1% of Canadians have...
”
Read Now
7
Clinical review report: Upadacitinib (Rinvoq) (AbbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate...
Published 2020
Canadian Agency for Drugs and Technologies in Health
“
... as well, including the
eyes
, lungs, heart, or skin. It is estimated that about 1% of Canadians have...
”
Back
Narrow Search
Remove Filters
Clear Filter
Author: CADTH Canadian Drug Expert Committee
Clear Filter
Language: English
Year of Publication
From:
To:
Classification
610 - Medicine & health
5
700 - The arts; fine & decorative arts
2
Language
English
Collection
National Center for Biotechnology Information
7
Author
CADTH Canadian Drug Expert Committee
Canadian Agency for Drugs and Technologies in Health
5
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22CADTH+Canadian+Drug+Expert+Committee%22&filter%5B%5D=language%3A%22English%22&lookfor=%22eye%22&type=AllFields
Send by Email
×
Loading...